Methods
Accepted on 11 Apr 2025
Federated Learning: A Privacy-Preserving Approach to Data-Centric Regulatory Cooperation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579922
- 189 views
78 Publications
Volume 5 - 2025
Review
Accepted on 07 Apr 2025
Corticosteroids in Lung Cancer
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1528468
Original Research
Published on 13 Mar 2025
Developing decision support algorithm for hypertension medications for use in a digital therapeutic system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
- 312 views
Editorial
Published on 11 Mar 2025
Editorial: External control arms for single-arm studies: methodological considerations and applications
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579171
- 579 views
Perspective
Published on 13 Feb 2025
Implementing tokenization in clinical research to expand real-world insights
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1519307
- 870 views
Volume 4 - 2024
Review
Published on 17 Jan 2025
Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1519142
- 786 views
Original Research
Published on 16 Jan 2025
The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1402684
- 898 views
Original Research
Published on 06 Jan 2025
Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1480515
- 955 views
Review
Published on 18 Dec 2024
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1418050
- 1,217 views
Original Research
Published on 06 Dec 2024
Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1497116
- 755 views
Mini Review
Published on 13 Nov 2024
Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1428831
- 846 views
Editorial
Published on 13 Nov 2024
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1517365
- 951 views
- 1 citation
Perspective
Published on 30 Oct 2024
External comparator studies and the joint application of the estimand and target trial emulation frameworks
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1409102
- 1,066 views
Opinion
Published on 18 Sep 2024
Achieving synchrony: bridging the gap between pharmaceutical companies and regulators on safety labeling updates
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1477516
- 1,385 views
- 1 citation
Original Research
Published on 17 Sep 2024
Demonstrating the principal mechanism of action of medical devices intended for vaginal use on reconstructed human vaginal epithelium: the case of two hyaluronic acid-containing devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445519
- 914 views
Original Research
Published on 16 Aug 2024
Exploring the scientific underpinnings of investigating safety signals: analytical insights in deciphering drug safety evidence
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445998
- 1,769 views
- 2 citations